Larvol Delta - Achieving-Remission-or-Very-Low-Disease-Activity-with-Bimekizumab-Resulted-in-Minimal-Radiographic-Progression-up-to-3-Years-in-Biological-DMARDNa239ve-Patients-with-Psoriatic-Arthritis

Bimzelx (bimekizumab-bkzx) - UCB

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1897495&mode=presInfo

Alice B. Gottlieb, MD, PhD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next